RecruitingNot ApplicableNCT04744935

Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma


Sponsor

Christopher Zachary

Enrollment

40 participants

Start Date

Jan 13, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Optical coherence tomography guided laser treatment of basal cell carcinoma


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether using optical coherence tomography (OCT) — a type of detailed skin imaging — to guide laser treatment of basal cell carcinoma (a common skin cancer) improves treatment outcomes by helping the doctor see exactly how far the cancer extends. **You may be eligible if...** - You are 18 or older - You have a basal cell carcinoma (BCC) that has already been confirmed by a prior biopsy - You are scheduled for treatment of this BCC - You or your legal guardian can understand and follow study instructions **You may NOT be eligible if...** - Your BCC is large (greater than 2.5 cm) or requires surgical excision - You have a BCC in a high-risk location (like the nose, eyelids, or ears) where laser therapy is not appropriate - You have a known allergy to the treatment materials used - You are immunocompromised Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICE1064 nm long-pulse Nd:YAG laser

BCC lesion will be treated with long-pulse 1064 laser, with surface temperature monitored by infrared camera.


Locations(1)

UCI Health Gottschalk Medical Plaza

Irvine, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04744935


Related Trials